A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis

Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis

(2017) Qi Wan et al.   OPHTHALMIC RESEARCH

Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis

(2016) Samrat Chatterjee et al.   CORNEA

Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis

(2016) OE Yücel et al.   SINGAPORE MEDICAL JOURNAL

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

(2014) Atsuki Fukushima et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Tacrolimus Ointment 0.03% for Treatment of Refractory Childhood Phlyctenular Keratoconjunctivitis

(2012) George D. Kymionis et al.   CORNEA

Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial

(2011) Stefan De Smedt et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis

(2011) A Kheirkhah et al.   EYE

A Randomized, Placebo-Controlled Clinical Trial of Tacrolimus Ophthalmic Suspension 0.1% in Severe Allergic Conjunctivitis

(2010) Yuichi Ohashi et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Vernal keratoconjunctivitis: a major review

(2008) Sunil Kumar   ACTA OPHTHALMOLOGICA

Allergy and the eye

(2008) A. Leonardi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY